ADO 0.00% 2.1¢ anteotech ltd

DCN - Clinical Study, page-19

  1. 234 Posts.
    lightbulb Created with Sketch. 37
    Another interesting company with similar cell, tissue, mineral or material binding capabilities might just be the competition that breaks the ADO projections. Try KODE biotech for interest.
 
watchlist Created with Sketch. Add ADO (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.